These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24028617)

  • 1. Hepatic and gastrointestinal first-pass effects of vitexin-4″-O-glucoside in rats.
    Chen Y; Zhang W; Li D; Ai J; Meng Y; Ying X; Kang T
    J Pharm Pharmacol; 2013 Oct; 65(10):1500-7. PubMed ID: 24028617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic, gastric, and intestinal first-pass effects of vitexin in rats.
    Xue HF; Ying ZM; Zhang WJ; Meng YH; Ying XX; Kang TG
    Pharm Biol; 2014 Aug; 52(8):967-71. PubMed ID: 24555505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC determination and pharmacokinetic study of vitexin-4″-O-glucoside in rat plasma after oral administration.
    Liu X; Wang D; Zhang W; Wang N; Wang S; Li H; Ying X; Kang T
    Nat Prod Res; 2012; 26(10):962-7. PubMed ID: 21834625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of vitexin-4″-O-glucoside in rats after intravenous application.
    Ying XX; Wang F; Cheng ZZ; Zhang WJ; Li HB; Du Y; Liu X; Wang SY; Kang TG
    Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):109-15. PubMed ID: 22058050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic, gastric and intestinal first-pass effects of vitexin-2''-O-rhamnoside in rats by ultra-high-performance liquid chromatography.
    Gao Y; Du Y; Ying Z; Leng A; Zhang W; Meng Y; Li C; Xu L; Ying X; Kang T
    Biomed Chromatogr; 2016 Feb; 30(2):111-6. PubMed ID: 26031900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
    J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH; Lee MG
    Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
    Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
    J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal first-pass metabolism by cytochrome p450 and not p-glycoprotein is the major barrier to amprenavir absorption.
    Dufek MB; Bridges AS; Thakker DR
    Drug Metab Dispos; 2013 Sep; 41(9):1695-702. PubMed ID: 23821186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect.
    Kang HE; Cho YK; Jung HY; Choi KY; Sohn SI; Baek SR; Lee MG
    Xenobiotica; 2009 Jun; 39(6):465-75. PubMed ID: 19480552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the excretion of vitexin-4''-O-glucoside in mice after oral and intravenous administration by using HPLC.
    Cai S; Chen Y; Zhang W; Ying X
    Biomed Chromatogr; 2013 Nov; 27(11):1375-9. PubMed ID: 23760836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
    Choi YH; Kim SG; Lee MG
    J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of gentiopicroside from Gentianae Radix and its pharmacokinetics on liver ischemia/reperfusion rats.
    Chang-Liao WL; Chien CF; Lin LC; Tsai TH
    J Ethnopharmacol; 2012 Jun; 141(2):668-73. PubMed ID: 21855624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein increases portal bioavailability of loperamide in mouse by reducing first-pass intestinal metabolism.
    Dufek MB; Knight BM; Bridges AS; Thakker DR
    Drug Metab Dispos; 2013 Mar; 41(3):642-50. PubMed ID: 23288866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.